Literature DB >> 16216352

Cytokines in acute coronary syndromes.

A L Pasqui, M Di Renzo, A Auteri, L Puccetti.   

Abstract

The aim of this study was to show the presence of an imbalance between pro-inflammatory and anti-inflammatory mediators in patients affected by acute coronary syndromes (ACS). We evaluated the production in cultured and stimulated lymphomonocytes of interferon (IFN)gamma and tumor necrosis factor (TNF)alpha, which are well known to possess pro-inflammatory effects, and of interleukin (IL)10, which has been shown to have a protective anti-inflammatory activity, in two groups of 30 patients affected by acute myocardial infarction (AMI) and unstable angina (UA), compared with two equivalent groups of patients with stable angina (SA) and of healthy volunteers. We found a significant increase of IFNgamma and TNFalpha production (p<0.01) and a significant decrease of IL-10 production (p<0.01) in cultures of lymphomonocytes taken from patients with AMI and UA compared with SA patients and controls. No significant changes were found between AMI and UA patients and SA patients and controls. We conclude that a relevant imbalance in cytokine release is present in ACS, markedly favoring pro-inflammatory effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216352     DOI: 10.1016/j.ijcard.2005.09.001

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Effects of ramipril on serum monocyte chemoattractant protein 1, interleukin-18, and interleukin-10 in elderly patients with acute coronary syndrome.

Authors:  Huan-qin Chen; Hong-yong Tan; Yi-wen Yang; Lei Qiu; Xiang-qun Liu
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

2.  Serum Cytokines Predict the Severity of Coronary Artery Disease Without Acute Myocardial Infarction.

Authors:  Sheng Liu; Chenyang Wang; Jinzhu Guo; Yunxiao Yang; Mengling Huang; Li Li; Yu Wang; Yanwen Qin; Ming Zhang
Journal:  Front Cardiovasc Med       Date:  2022-05-16

3.  Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning.

Authors:  Yongyi Wang; Baofu Chen; Dafu Shen; Song Xue
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

Review 4.  Systemic inflammatory response following acute myocardial infarction.

Authors:  Lu Fang; Xiao-Lei Moore; Anthony M Dart; Le-Min Wang
Journal:  J Geriatr Cardiol       Date:  2015-05       Impact factor: 3.327

5.  Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan.

Authors:  Romina Navarri; Stefano Lunghetti; Matteo Cameli; Sergio Mondillo; Roberto Favilli; Francesca Scarpini; Luca Puccetti
Journal:  Int J Cardiol Heart Vasc       Date:  2014-11-13

6.  Apoptosis and Mobilization of Lymphocytes to Cardiac Tissue Is Associated with Myocardial Infarction in a Reperfused Porcine Model and Infarct Size in Post-PCI Patients.

Authors:  Maria J Forteza; Isabel Trapero; Arantxa Hervas; Elena de Dios; Amparo Ruiz-Sauri; Gema Minana; Clara Bonanad; Cristina Gómez; Ricardo Oltra; Cesar Rios-Navarro; Daniel F J Ketelhuth; Julio Nunez; Francisco J Chorro; Vicente Bodi
Journal:  Oxid Med Cell Longev       Date:  2018-03-18       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.